F Ansaldi

Summary

Affiliation: University of Genoa
Country: Italy

Publications

  1. pmc Neutralizing and hemagglutination-inhibiting activities of antibodies elicited by the 2004-2005 influenza vaccine against drifted viruses
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Via Pastore 1, 16100 Genoa, Italy
    Clin Vaccine Immunol 13:162-4. 2006
  2. doi request reprint Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
    Filippo Ansaldi
    CIRI IV, Department of Health Sciences, University of Genoa, Genoa, Italy
    Vaccine 26:1525-9. 2008
  3. pmc Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults
    Filippo Ansaldi
    I R C C S A O U San Martino IST Genoa, Italy
    Hum Vaccin Immunother 8:1048-52. 2012
  4. ncbi request reprint Bacterial carriage and respiratory tract infections in subjects > or = 60 years during an influenza season: implications for the epidemiology of community acquired pneumonia and influenza vaccine effectiveness
    F Ansaldi
    Department of Health Sciences, University of Genoa, Italy
    J Prev Med Hyg 53:94-7. 2012
  5. doi request reprint Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses
    Filippo Ansaldi
    Dept of Health Sciences, University of Genoa, Italy
    Vaccine 30:2908-13. 2012
  6. doi request reprint Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Via Pastore 1, 16132 Genoa, Italy
    Vaccine 30:2288-94. 2012
  7. pmc New A/H3N2 influenza variant: a small genetic evolution but a heavy burden on the Italian population during the 2004-2005 season
    Filippo Ansaldi
    CIRI IV, Department of Health Sciences, University of Genoa, Genoa, Italy
    J Clin Microbiol 43:3027-9. 2005
  8. pmc Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Via Pastore 1, 16100 Genoa, Italy
    J Clin Microbiol 45:1011-5. 2007
  9. ncbi request reprint Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Via Pastore 1, Genoa, Italy
    Eur J Epidemiol 23:45-53. 2008
  10. doi request reprint Burden of rotavirus-associated and non-rotavirus-associated diarrhea among nonhospitalized individuals in central Italy: a 1-year sentinel-based epidemiological and virological surveillance
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    Clin Infect Dis 46:e51-5. 2008

Detail Information

Publications58

  1. pmc Neutralizing and hemagglutination-inhibiting activities of antibodies elicited by the 2004-2005 influenza vaccine against drifted viruses
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Via Pastore 1, 16100 Genoa, Italy
    Clin Vaccine Immunol 13:162-4. 2006
    ....
  2. doi request reprint Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
    Filippo Ansaldi
    CIRI IV, Department of Health Sciences, University of Genoa, Genoa, Italy
    Vaccine 26:1525-9. 2008
    ..Thus, MF59-adjuvanted vaccine confers greater immunogenicity than non-adjuvanted vaccines in vulnerable populations...
  3. pmc Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults
    Filippo Ansaldi
    I R C C S A O U San Martino IST Genoa, Italy
    Hum Vaccin Immunother 8:1048-52. 2012
    ..In conclusion, the recently available low-antigen-content ID vaccine is safe, well-tolerated and as immunogenic as IM standard-dose influenza vaccine...
  4. ncbi request reprint Bacterial carriage and respiratory tract infections in subjects > or = 60 years during an influenza season: implications for the epidemiology of community acquired pneumonia and influenza vaccine effectiveness
    F Ansaldi
    Department of Health Sciences, University of Genoa, Italy
    J Prev Med Hyg 53:94-7. 2012
    ....
  5. doi request reprint Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses
    Filippo Ansaldi
    Dept of Health Sciences, University of Genoa, Italy
    Vaccine 30:2908-13. 2012
    ..This study, although limited in the size of study population, demonstrated the broader immune response elicited by an ID influenza vaccine vs. a standard IM influenza vaccine against heterologous viruses including field isolates...
  6. doi request reprint Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Via Pastore 1, 16132 Genoa, Italy
    Vaccine 30:2288-94. 2012
    ....
  7. pmc New A/H3N2 influenza variant: a small genetic evolution but a heavy burden on the Italian population during the 2004-2005 season
    Filippo Ansaldi
    CIRI IV, Department of Health Sciences, University of Genoa, Genoa, Italy
    J Clin Microbiol 43:3027-9. 2005
  8. pmc Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Via Pastore 1, 16100 Genoa, Italy
    J Clin Microbiol 45:1011-5. 2007
    ....
  9. ncbi request reprint Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Via Pastore 1, Genoa, Italy
    Eur J Epidemiol 23:45-53. 2008
    ..In the period from 1998 to 2005, the incidence drastically decreased (average of 3.2/100,000 inhabitants), reaching a minimum of 2/100,000 inhabitants in 2005...
  10. doi request reprint Burden of rotavirus-associated and non-rotavirus-associated diarrhea among nonhospitalized individuals in central Italy: a 1-year sentinel-based epidemiological and virological surveillance
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    Clin Infect Dis 46:e51-5. 2008
    ..1% and 41.7%, respectively). Approximately one-third of gastroenteritis cases requiring an office visit or telephone consultation were attributable to rotavirus infection...
  11. ncbi request reprint Molecular epidemiology and case-control approaches for management of an outbreak of hepatitis A in Liguria, Italy
    F Ansaldi
    Department of Health Sciences, University of Genoa, Italy
    J Prev Med Hyg 48:103-8. 2007
    ....
  12. doi request reprint Syndrome surveillance and molecular epidemiology for early detection and tracing of an outbreak of measles in Liguria, Italy
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    J Med Virol 81:1807-13. 2009
    ..Syndrome surveillance integrated with a rapid detection and characterization of the agent responsible for the disease could be an effective, specific and sensitive tool for measles surveillance...
  13. ncbi request reprint Emergency department syndromic surveillance system for early detection of 5 syndromes: a pilot project in a reference teaching hospital in Genoa, Italy
    F Ansaldi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    J Prev Med Hyg 49:131-5. 2008
    ....
  14. ncbi request reprint Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection
    F Ansaldi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    J Viral Hepat 13:5-10. 2006
    ....
  15. doi request reprint Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates
    Filippo Ansaldi
    CIRI IV, Department of Health Sciences, University of Genoa, Via Pastore 1, 16100 Genoa, Italy
    Vaccine 28:4123-9. 2010
    ..These data show that seasonal influenza vaccine adjuvanted with MF59 can offer a stronger benefit as compared to non-adjuvanted vaccine in protecting against a broader range of virus strains circulating during the influenza season...
  16. doi request reprint Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa CIRI IV, Inter University Research Centre on Influenza, Via Pastore 1, 16132 Genoa, Italy
    Vaccine 27:3345-8. 2009
    ..Promising results were obtained using a new generation of oil-in-water emulsion adjuvants, named AS, offering cross-protection against heterologous challenge in ferrets...
  17. doi request reprint Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccines
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    Hum Vaccin 7:211-6. 2011
    ....
  18. pmc Increasing incidence of Streptococcus pneumoniae serotype 19A and emergence of two vaccine escape recombinant ST695 strains in Liguria, Italy, 7 years after implementation of the 7-valent conjugated vaccine
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Genoa 16100, Italy
    Clin Vaccine Immunol 18:343-5. 2011
    ..To our knowledge, this is the first detection of an occurrence of capsular switching outside the United States...
  19. ncbi request reprint Antigenic characterisation of influenza B virus with a new microneutralisation assay: comparison to haemagglutination and sequence analysis
    Filippo Ansaldi
    C I R I, Department of Health Sciences, University of Genoa, Genoa, Italy
    J Med Virol 74:141-6. 2004
    ....
  20. ncbi request reprint Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    J Med Virol 76:327-32. 2005
    ....
  21. doi request reprint Sequential outbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation
    F Ansaldi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    J Hosp Infect 79:134-40. 2011
    ..A molecular approach allowed the prompt introduction of infection control measures and the evaluation of data in a global epidemiological context...
  22. ncbi request reprint Influenza and respiratory syncytial virus in infants and children: relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains
    R Gasparini
    Interuniversity Centre for Research on Influenza and Viral Infections CIRI IV, Department of Health Sciences, University of Genoa, Italy
    Eur J Clin Microbiol Infect Dis 26:619-28. 2007
    ..A/H3N2 strains belonged to two clusters, A/Panama/2007/99-like and A/Fujian/411/02-like, a new variant. This paper discusses the possible role of the identified flu strains in determining EUARs among the population by age class...
  23. pmc Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults
    P Durando
    Department of Health Sciences, University of Genoa, 16132 Genoa, Italy
    Clin Vaccine Immunol 15:253-9. 2008
    ..The results showed good safety and immunogenicity for both vaccines under study for both uninfected and HIV-1-infected adults, confirming current recommendations for immunization of this high-risk category...
  24. ncbi request reprint Performance testing of two new one-step real time PCR assays for detection of human influenza and avian influenza viruses isolated in humans and respiratory syncytial virus
    L Valle
    CIRI IV, Department of Health Sciences, University of Genoa, Italy
    J Prev Med Hyg 47:127-33. 2006
    ..Specificity, analytical and clinical sensitivity, dynamic range, linearity of the new assays were evaluated...
  25. ncbi request reprint Decline in pneumonia and acute otitis media after the introduction of childhood pneumococcal vaccination in Liguria, Italy
    F Ansaldi
    Department of Health Sciences, University of Genoa, Italy
    J Int Med Res 36:1255-60. 2008
    ..2% for all cause pneumonia to 70.5% for pneumococcal pneumonia. This study contributes to the growing body of information that supports the beneficial effect of PCV7 vaccination...
  26. ncbi request reprint Impact of influenza during the post-pandemic season: epidemiological picture from syndromic and virological surveillance
    D de Florentiis
    CIRI IV, Department of Health Sciences, University of Genoa, Italy
    J Prev Med Hyg 52:134-6. 2011
    ..We described the epidemiological picture emerged from syndromic and virological surveillance during the post-pandemic season in Liguria, Italy...
  27. ncbi request reprint Evaluation of a new hepatitis C virus sequencing assay as a routine method for genotyping
    F Ansaldi
    Department of Health Sciences, University of Genoa, Italy
    J Med Virol 63:17-21. 2001
    ..One LiPA genotype 1a sample was typed as 1b and 2 genotype 1b samples were all typed as 1a by the sequence analysis. In conclusion, the new assay is a sensitive and rapid method that is suitable for accurate large-scale genotyping...
  28. ncbi request reprint Hospital-acquired infections and leading pathogens detected in a regional university adult acute-care hospital in Genoa, Liguria, Italy: results from a prevalence study
    P Durando
    Department of Health Sciences, Section of Hygiene and Preventive Medicine, University of Genoa and San Martino University Hospital of Genoa, Italy
    J Prev Med Hyg 51:80-6. 2010
    ....
  29. ncbi request reprint Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study
    F Ansaldi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    J Int Med Res 33:490-500. 2005
    ....
  30. ncbi request reprint Role of congenital rubella reference laboratory: 21-months-surveillance in Liguria, Italy
    P Canepa
    Doctoral School in Clinical and Experimental Medicine, University of Genoa, Italy
    J Prev Med Hyg 50:221-6. 2009
    ..Since June 2006, Liguria Administrative Region recognized U.O. Hygiene, "San Martino" University Hospital, Genoa, as regional reference laboratory for diagnosis of rubella infection during pregnancy and post-partum...
  31. pmc Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen
    G Icardi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    J Clin Microbiol 39:3110-4. 2001
    ..In conclusion, the HCV antigen assay showed high sensitivity and specificity and could become a useful means of improving the safety of blood and blood products...
  32. ncbi request reprint Ostreopsis ovata and human health: epidemiological and clinical features of respiratory syndrome outbreaks from a two-year syndromic surveillance, 2005-06, in north-west Italy
    P Durando
    Department of Health Sciences, Section of Hygiene and Preventive Medicine, San Martino Hospital, University of Genoa, Genoa, Italy
    Euro Surveill 12:E070607.1. 2007
  33. doi request reprint Surveillance of hospital-acquired infections in Liguria, Italy: results from a regional prevalence study in adult and paediatric acute-care hospitals
    P Durando
    Department of Health Sciences, Section of Hygiene and Preventive Medicine, University of Genoa and San Martino University Hospital of Genoa, Italy
    J Hosp Infect 71:81-7. 2009
    ..Our study provides an overall picture of the epidemiology of HAI in Liguria, which may be usefully employed as a starting point to plan and organise future surveillance and control programmes...
  34. ncbi request reprint Evaluation of microbial contamination of air in two haematology departments equipped with ventilation systems with different filtration devices
    P Crimi
    Department of Health Sciences, San Martino Hospital, University of Genoa, Italy
    J Prev Med Hyg 50:33-6. 2009
    ..In this study, we evaluated microbial contamination of the air in two divisions with high risk patients, focusing on the validity of the air system with correlation to the presence or not of the HEPA absolute filters...
  35. doi request reprint Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy)
    D Panatto
    Department of Health Science, University of Genoa, Via Pastore 1, 16132 Genoa, Italy
    Vaccine 27:3450-3. 2009
    ..From the perspective of both the RHS and S, vaccination proved to be highly cost-effective...
  36. doi request reprint Human papillomavirus vaccination: what is the best choice? A comparison of 16 strategies by means of a decisional model
    R Gasparini
    Department of Health Sciences of Genoa University, Genoa, Italy
    Epidemiol Infect 137:794-802. 2009
    ..Indeed, it could generate interesting savings for the National Health Service and a rapid HPV immunization of young girls...
  37. ncbi request reprint Identification of key mutations in HIV reverse transcriptase gene can influence the clinical outcome of HAART
    M Setti
    Department of Internal Medicine, University of Genoa, Italy
    J Med Virol 64:199-206. 2001
    ..Although the interpretation of resistance-related key mutations needs improvement, this surrogate LiPA method seems to maintain a predictive role in the management of HIV infection, and is less expensive...
  38. ncbi request reprint Antiviral activity of amantadine in elderly patients with chronic hepatitis C
    F Torre
    Department of Internal Medicine, University of Genoa, Italy
    Gerontology 47:330-3. 2001
    ..CONCLUSIONS: Our results confirm the antiviral activity of amantadine against HCV, mainly for genotype 1b with initial high viral load. No consistent effects on aminotransferases were observed...
  39. ncbi request reprint Impact of limited cephalosporin use on prevalence of methicillin-resistant Staphylococcus aureus in the intensive care unit
    M Bassetti
    Infectious Diseases Division, S Martino Hospital and University of Genoa School of Medicine, Genoa, Italy
    J Chemother 21:633-8. 2009
    ..5%). A significant reduction in the percentage of MRSA infections (-30%) and heterogeneous susceptibility patterns in Klebsiella pneumoniae and Pseudomonas aeruginosa were noted...
  40. doi request reprint Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients
    Maurizio Setti
    Clinic of Internal Medicine and Clinical Immunology, Department of Internal Medicine DIMI, San Martino Hospital, University of Genoa, Viale Benedetto XV 6, 16153 Genoa, Italy
    Vaccine 27:3367-72. 2009
    ..Inflexal was found effective in scleroderma patients. In no subject was worsening of clinical conditions, inflammation and immunological parameters observed...
  41. doi request reprint Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement
    Filippo Ansaldi
    University of Genoa, Department of Health Sciences, Via Pastore 1, Genoa, 16132, Italy
    Expert Opin Biol Ther 11:415-27. 2011
    ..These have included an increased dosage, multiple dose vaccinations, use of vaccine adjuvants and more efficient routes of vaccine delivery...
  42. doi request reprint MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk
    Paolo Durando
    Department of Health Sciences Section of Hygiene and Preventive Medicine, University of Genoa, Head of the Outpatient Clinic of the Hygiene Unit, San Martino University Hospital, Via Pastore 1 16132, Genoa, Italy
    Expert Opin Biol Ther 10:639-51. 2010
    ..The protection offered by non-adjuvanted vaccines may be further reduced by periodic antigenic drifts...
  43. doi request reprint Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy
    Paolo Durando
    Department of Health Sciences, San Martino Hospital, University of Genoa, Via A Pastore 1, 16132 Genoa, Italy
    Vaccine 27:3459-62. 2009
    ..2%, 70.5% and 36.4%, respectively...
  44. ncbi request reprint Influenza vaccination in HIV-positive subjects: latest evidence and future perspective
    A Ceravolo
    Department of Health Sciences, University of Genoa, Italy
    J Prev Med Hyg 54:1-10. 2013
    ..The aim of this review is to evaluate tolerability, safety, immunogenicity and efficacy of vaccines actually approved for human use and to consider latest evidence and future perspective in HIV positive subjects...
  45. ncbi request reprint A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects?
    G Icardi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    Ann Ig 15:863-70. 2003
    ..In conclusion, we found that the results from the total HCV Ag test agree with the RT-PCR results and therefore we believe that this test could become a useful tool for the diagnosis and management of HCV infection...
  46. ncbi request reprint Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer
    F M Boccardo
    Department of Surgery, Unit of Lymphatic Surgery and Microsurgery, S Martino Hospital, University of Genoa, Italy
    Lymphology 42:1-9. 2009
    ..These prophylactic strategies appear to reduce the development of secondary lymphedema and alter its progression in comparison to the CG women...
  47. ncbi request reprint Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients
    Edoardo Giannini
    Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Italy
    Liver Int 23:12-8. 2003
    ..Moreover, they may carry occult HBV infection. These features might influence clinical and biochemical features as well as stage of disease...
  48. doi request reprint Simultaneous detection of anti-HCV antibody and HCV core antigen
    Filippo Ansaldi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    Methods Mol Biol 510:15-23. 2009
    ....
  49. ncbi request reprint Silymarin and S-adenosyl-L-methionine (SAMe): two promising pharmacological agents in case of chronic alcoholic hepathopathy. A review and a point of view
    G Testino
    Centro Alcologico Regionale Regione Liguria Unità Operativa di Alcologia e Patologie Correlate, Department of General Internal and Specialistic Medicine Irccs AOU San Martino National Institute for CancerResearch, Genoa, Italy
    Minerva Gastroenterol Dietol 59:341-56. 2013
    ..It could be beneficial in such cases of alcoholic hepathopathies. New therapeutic options are needed by hepatologists to successfully overcome a constantly growing disease. ..
  50. doi request reprint Incidence of candidaemia and relationship with fluconazole use in an intensive care unit
    Matteo Bassetti
    Infectious Diseases Division, San Martino Hospital and University of Genoa School of Medicine, Genoa, Italy
    J Antimicrob Chemother 64:625-9. 2009
    ..The aim of this study was to evaluate trends in the incidence of candidaemia and the distribution of Candida albicans and non-albicans over a 9 year period (1999-2007), and to assess their relationship with fluconazole use...
  51. ncbi request reprint Rotavirus vaccines: considerations for successful implementation in Europe
    Pierre Van Damme
    Centre for the Evaluation of Vaccination, University of Antwerp, Belgium
    Lancet Infect Dis 6:805-12. 2006
    ..Further studies on the cost of the disease and the benefit of vaccination, together with raising awareness are necessary steps to ensure successful implementation of rotavirus vaccination in Europe...
  52. ncbi request reprint Molecular characterization of influenza B viruses circulating in northern Italy during the 2001-2002 epidemic season
    Filippo Ansaldi
    Department of Public Medicine Sciences, U C O Hygiene and Preventive Medicine, University of Trieste and IRCCS Burlo Garofolo, Trieste, Italy
    J Med Virol 70:463-9. 2003
    ....
  53. ncbi request reprint An outbreak of influenza in a residential drug-rehabilitation community
    Antonio Boschini
    Medical Center, San Patrignano Community, Rimini, Italy
    J Med Virol 78:1218-22. 2006
    ..13, 95% CI: 2.52-10.20). The outbreak was attributable to Christchurch-like influenza A strains. Vaccination was ineffective because of the mismatch between wild and vaccine strains...
  54. ncbi request reprint Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy
    Gianna Dal Molin
    Department of Public Medicine Sciences, UCO Hygiene and Preventive Medicine, University of Trieste, and IRCCS Burlo Garofolo, Trieste, Italy
    J Med Virol 68:352-6. 2002
    ..5% and 66.6%, respectively). Logistic regression showed that age and injection drug use are independent determinants of genotype distribution...
  55. ncbi request reprint Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti-HCV as risk factors
    Gianna Dal Molin
    Department of Public Medicine Sciences, U C O Hygiene and Preventive Medicine, University of Trieste and IRCCS Burlo Garofolo, Trieste, Italy
    J Med Virol 67:137-42. 2002
    ..R. = 14.5; 95% CI: 1.3-160.7 and O.R. = 16.3; 95% CI: 1.5-179.9, respectively)...
  56. ncbi request reprint Changes in the hemagglutinins and neuraminidases of human influenza B viruses isolated in Italy during the 2001-02, 2002-03, and 2003-04 seasons
    Simona Puzelli
    Laboratory of Virology, National Influenza Centre, Istituto Superiore di Sanita, Rome, Italy
    J Med Virol 74:629-40. 2004
    ..The frequency of reassortment between HA and NA of distinct lineages and sublineages highlights again the importance of detailed molecular analyses of both surface glycoproteins in understanding the evolution of influenza B viruses...
  57. ncbi request reprint Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis
    Gianni Testino
    Unit of Hepato Gastroenterology, S Martino Hospital, Italy
    Hepatogastroenterology 49:1636-8. 2002
    ....
  58. ncbi request reprint Anti-transglutaminase antibodies and age
    Valentina Baldas
    Clinica Pediatrica, Istituto d Igiene, Dipartimento di Biologia, Universita di Trieste, Italy
    Clin Chem 50:1856-60. 2004